Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes.

Bell D, Bell AH, Kupferman ME, Prieto VG, Weber RS, Hanna EY.

Head Neck. 2019 Apr 30. doi: 10.1002/hed.25795. [Epub ahead of print]

PMID:
31041828
2.

Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry.

Amit M, Hutcheson K, Zaveri J, Lewin J, Kupferman ME, Hessel AC, Goepfert RP, Brandon Gunn G, Garden AS, Ferraratto R, Dave Fuller C, Tam S, Gross ND.

Oral Oncol. 2019 Apr;91:13-20. doi: 10.1016/j.oraloncology.2019.01.020. Epub 2019 Feb 16.

PMID:
30926057
3.

Pediatric Craniomaxillofacial Oncologic Reconstruction.

Dempsey RF, Chelius DC Jr, Pederson WC, Maricevich M, Dimachkieh AL, Kupferman ME, Weiner HL, Hollier LH Jr, Buchanan EP.

Clin Plast Surg. 2019 Apr;46(2):261-273. doi: 10.1016/j.cps.2018.11.011. Epub 2019 Jan 30. Review.

PMID:
30851757
4.

Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies.

Tyler MA, Mohamed ASR, Smith JB, Aymard JM, Fuller CD, Phan J, Frank SJ, Ferrarotto R, Kupferman ME, Hanna EY, Gunn GB, Su SY.

Laryngoscope. 2019 Feb 1. doi: 10.1002/lary.27849. [Epub ahead of print]

PMID:
30706478
5.

Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.

Amit M, Abdelmeguid AS, Watcherporn T, Takahashi H, Tam S, Bell D, Ferrarotto R, Glisson B, Kupferman ME, Roberts DB, Su SY, Raza SM, DeMonte F, Hanna EY.

J Clin Oncol. 2019 Feb 20;37(6):504-512. doi: 10.1200/JCO.18.00353. Epub 2019 Jan 7.

6.

Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity.

Mays AC, Hanna EY, Ferrarotto R, Phan J, Bell D, Silver N, Mulcahy CF, Roberts D, Abdelmeguid ASA, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Su SY.

Head Neck. 2018 Dec;40(12):2596-2605. doi: 10.1002/hed.25335. Epub 2018 Nov 17.

PMID:
30447126
7.

A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?

Ng SP, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn GB, Phan J, Zafereo M, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai S, Rosenthal D, Fuller CD.

Clin Transl Radiat Oncol. 2018 Aug 2;12:40-46. doi: 10.1016/j.ctro.2018.07.006. eCollection 2018 Aug.

8.

Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.

Heah H, Goepfert RP, Hutcheson KA, Garden AS, Gunn GB, Fuller CD, Lewin JS, Kupferman ME, Holsinger FC, Hessel AC, Gross ND.

Head Neck. 2018 Nov;40(11):2507-2513. doi: 10.1002/hed.25382. Epub 2018 Aug 13.

PMID:
30102824
9.

Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension.

Mehta GU, DeMonte F, Su SY, Kupferman ME, Hanna EY, Raza SM.

J Neurosurg. 2018 Jul 1:1-8. doi: 10.3171/2018.3.JNS172722. [Epub ahead of print]

PMID:
30074455
10.

Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.

Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY.

Ann Surg Oncol. 2018 Jun;25(6):1723-1729. doi: 10.1245/s10434-018-6465-y. Epub 2018 Apr 6.

PMID:
29626308
11.

Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma.

Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL Jr, Waguespack SG, Perrier ND, Grubbs EG.

Ann Surg Oncol. 2018 May;25(5):1395-1402. doi: 10.1245/s10434-018-6366-0. Epub 2018 Feb 9.

PMID:
29427212
12.

Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma.

Freeman JL, DeMonte F, Al-Holou W, Gidley PW, Hanna EY, Kupferman ME, Su SY, Raza SM.

Acta Neurochir (Wien). 2018 Apr;160(4):731-740. doi: 10.1007/s00701-017-3409-4. Epub 2017 Dec 21.

PMID:
29270681
13.

Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.

Mays AC, Bell D, Ferrarotto R, Phan J, Roberts D, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Hanna EY, Su SY.

Laryngoscope. 2018 Jun;128(6):1274-1280. doi: 10.1002/lary.26908. Epub 2017 Dec 11.

PMID:
29226334
14.

Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma.

Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY.

J Neurol Surg B Skull Base. 2017 Dec;78(6):512-518. doi: 10.1055/s-0037-1604350. Epub 2017 Jul 31.

15.

Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma.

Amit M, Tam S, Abdelmeguid AS, Roberts DB, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY.

Cancer. 2018 Feb 1;124(3):514-520. doi: 10.1002/cncr.31083. Epub 2017 Oct 17.

16.

Brain derived neutrophic factor (BDNF) coordinates lympho-vascular metastasis through a fibroblast-governed paracrine axis in the tumor microenvironment.

Jiffar T, Yilmaz T, Lee J, Miller Y, Feng L, El-Naggar A, Kupferman ME.

Cancer Cell Microenviron. 2017;4(2). pii: e1566. doi: 10.14800/ccm.1566. Epub 2017 Jul 10.

17.

Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas.

Raza SM, Gidley PW, Kupferman ME, Hanna EY, Su SY, DeMonte F.

Oper Neurosurg (Hagerstown). 2018 Jun 1;14(6):611-619. doi: 10.1093/ons/opx171.

PMID:
28962038
18.

Microsurgical Reconstruction Following Oncologic Resection in Pediatric Patients: A 15-Year Experience.

Starnes-Roubaud MJ, Hanasono MM, Kupferman ME, Liu J, Chang EI.

Ann Surg Oncol. 2017 Dec;24(13):4009-4016. doi: 10.1245/s10434-017-6061-6. Epub 2017 Sep 7.

PMID:
28884452
19.

Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module.

Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB; MD Anderson Head and Neck Cancer Symptom Working Group.

Head Neck. 2017 Oct;39(10):2048-2056. doi: 10.1002/hed.24876. Epub 2017 Aug 1.

20.

Outcomes for olfactory neuroblastoma treated with induction chemotherapy.

Su SY, Bell D, Ferrarotto R, Phan J, Roberts D, Kupferman ME, Frank SJ, Fuller CD, Gunn GB, Kies MS, Glisson BS, Hanna EY.

Head Neck. 2017 Aug;39(8):1671-1679. doi: 10.1002/hed.24822. Epub 2017 May 31.

PMID:
28561956
21.

Transoral endoscopic head and neck surgery (eHNS) for minor salivary gland tumors of the oropharynx.

Schoppy DW, Kupferman ME, Hessel AC, Bell DM, Garland EM, Damrose EJ, Holsinger FC.

Cancers Head Neck. 2017 May 31;2:5. doi: 10.1186/s41199-017-0024-2. eCollection 2017.

22.

Mutation status among patients with sinonasal mucosal melanoma and its impact on survival.

Amit M, Tam S, Abdelmeguid AS, Roberts DB, Takahashi Y, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY.

Br J Cancer. 2017 Jun 6;116(12):1564-1571. doi: 10.1038/bjc.2017.125. Epub 2017 May 11.

23.

Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations.

Klein JD, Kupferman ME.

Head Neck. 2017 Feb;39(2):E20-E22. doi: 10.1002/hed.24594. Epub 2016 Oct 11. Review.

PMID:
27726232
24.

Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.

Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN Jr, Frank SJ.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):30-41. doi: 10.1016/j.ijrobp.2016.03.053. Epub 2016 Apr 13.

PMID:
27325480
25.

The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.

Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):241-7. doi: 10.1016/j.prro.2015.10.023. Epub 2015 Nov 10.

26.

Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma.

Takahashi Y, Lee J, Pickering C, Bell D, Jiffar TW, Myers JN, Hanna EY, Kupferman ME.

Head Neck. 2016 Apr;38 Suppl 1:E1926-34. doi: 10.1002/hed.24350. Epub 2016 Jan 11.

27.

Noninvasive intraoperative angiography for reconstruction of head and neck defects.

Daram SP, Sacks JM, Kupferman ME.

Ear Nose Throat J. 2015 Oct-Nov;94(10-11):E32-6.

PMID:
26535829
28.

Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study.

de Almeida JR, Li R, Magnuson JS, Smith RV, Moore E, Lawson G, Remacle M, Ganly I, Kraus DH, Teng MS, Miles BA, White H, Duvvuri U, Ferris RL, Mehta V, Kiyosaki K, Damrose EJ, Wang SJ, Kupferman ME, Koh YW, Genden EM, Holsinger FC.

JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1043-1051. doi: 10.1001/jamaoto.2015.1508.

29.

Surgical Management of a Functional Paraganglioma of the Infratemporal Fossa.

Tritter AG, Selber J, Kupferman ME.

J Neurol Surg Rep. 2015 Jul;76(1):e1-7. doi: 10.1055/s-0034-1383860. Epub 2015 Jan 16.

30.

Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics.

Grant SR, Grosshans DR, Bilton SD, Garcia JA, Amin M, Chambers MS, McGovern SL, McAleer MF, Morrison WH, Huh WW, Kupferman ME, Mahajan A.

Radiother Oncol. 2015 Aug;116(2):309-15. doi: 10.1016/j.radonc.2015.07.022. Epub 2015 Jul 28.

31.

Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.

Monroe MM, Pattisapu P, Myers JN, Kupferman ME.

Otolaryngol Head Neck Surg. 2015 Sep;153(3):372-8. doi: 10.1177/0194599815589948. Epub 2015 Jun 12.

PMID:
26070510
32.

Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy.

Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J.

Head Neck. 2016 Apr;38 Suppl 1:E925-33. doi: 10.1002/hed.24128. Epub 2015 Jul 18.

PMID:
25994561
33.

Cutaneous malignancy of the head and neck.

Mydlarz WK, Weber RS, Kupferman ME.

Surg Oncol Clin N Am. 2015 Jul;24(3):593-613. doi: 10.1016/j.soc.2015.03.010. Epub 2015 Apr 8. Review.

PMID:
25979402
34.

Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management.

Raza SM, Ramakrishna R, Weber RS, Kupferman ME, Gidley PW, Hanna EY, DeMonte F.

J Neurosurg. 2015 Sep;123(3):781-8. doi: 10.3171/2014.10.JNS141037. Epub 2015 Apr 24.

PMID:
25909577
35.

Prognostic factors in adenocarcinoma of the salivary glands.

Huang AT, Tang C, Bell D, Yener M, Izquierdo L, Frank SJ, El-Naggar AK, Hanna EY, Weber RS, Kupferman ME.

Oral Oncol. 2015 Jun;51(6):610-5. doi: 10.1016/j.oraloncology.2015.03.005. Epub 2015 Apr 2.

PMID:
25843792
36.

Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy.

Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J.

Head Neck. 2016 Apr;38 Suppl 1:E580-7. doi: 10.1002/hed.24044. Epub 2015 Jul 6.

PMID:
25782700
37.

Comparative effectiveness in head and neck malignancies.

Lewis CM, Hutcheson KA, Kupferman ME.

Cancer Treat Res. 2015;164:89-99. doi: 10.1007/978-3-319-12553-4_6.

PMID:
25677020
38.

Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands.

Su YX, Roberts DB, Hanna EY, El-Naggar A, Saylam G, Frank SJ, Weber RS, Kupferman ME.

Ann Surg Oncol. 2015 Oct;22(11):3701-7. doi: 10.1245/s10434-015-4389-3. Epub 2015 Jan 31.

PMID:
25636455
39.

Impact of Chemoradiotherapy on CSF Leak Repair after Skull Base Surgery.

Alves MV, Roberts D, Levine NB, DeMonte F, Hanna EY, Kupferman ME.

J Neurol Surg B Skull Base. 2014 Oct;75(5):354-7. doi: 10.1055/s-0034-1373659. Epub 2014 Jun 4.

40.

Robotic surgery of the skull base.

Kupferman ME, Hanna E.

Otolaryngol Clin North Am. 2014 Jun;47(3):415-23. doi: 10.1016/j.otc.2014.02.004. Epub 2014 Apr 6. Review.

PMID:
24882799
41.

Transoral laser surgery for laryngeal cancer.

Sandulache VC, Kupferman ME.

Rambam Maimonides Med J. 2014 Apr 28;5(2):e0012. doi: 10.5041/RMMJ.10146. eCollection 2014 Apr.

42.

Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.

Davis-Malesevich MV, Goepfert R, Kubik M, Roberts DB, Myers JN, Kupferman ME.

Head Neck. 2015 Aug;37(8):1116-21. doi: 10.1002/hed.23718. Epub 2014 Jul 11.

PMID:
24764188
43.

Functional outcomes after TORS for oropharyngeal cancer: a systematic review.

Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS.

Eur Arch Otorhinolaryngol. 2015 Feb;272(2):463-71. doi: 10.1007/s00405-014-2985-7. Epub 2014 Mar 19. Review.

44.

Phase II study of gefitinib in patients with advanced salivary gland cancers.

Jakob JA, Kies MS, Glisson BS, Kupferman ME, Liu DD, Lee JJ, El-Naggar AK, Gonzalez-Angulo AM, Blumenschein GR Jr.

Head Neck. 2015 May;37(5):644-9. doi: 10.1002/hed.23647. Epub 2015 Mar 30.

45.

Endoscopic resection of sinonasal cancers.

Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY.

Curr Oncol Rep. 2014 Feb;16(2):369. doi: 10.1007/s11912-013-0369-6. Review.

PMID:
24445501
46.

The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck.

Kupferman ME, Kubik MW, Bradford CR, Civantos FJ, Devaney KO, Medina JE, Rinaldo A, Stoeckli SJ, Takes RP, Ferlito A.

Am J Otolaryngol. 2014 Mar-Apr;35(2):226-32. doi: 10.1016/j.amjoto.2013.12.004. Epub 2013 Dec 12. Review.

PMID:
24439782
47.

Genetic testing in head and neck paraganglioma: who, what, and why?

Sridhara SK, Yener M, Hanna EY, Rich T, Jimenez C, Kupferman ME.

J Neurol Surg B Skull Base. 2013 Aug;74(4):236-40. doi: 10.1055/s-0033-1342924. Epub 2013 Apr 12.

48.

Prognostic factors associated with decreased survival in patients with acinic cell carcinoma.

Neskey DM, Klein JD, Hicks S, Garden AS, Bell DM, El-Naggar AK, Kies MS, Weber RS, Kupferman ME.

JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1195-202. doi: 10.1001/jamaoto.2013.4728.

49.

Sinonasal adenocarcinoma: a 16-year experience at a single institution.

Bhayani MK, Yilmaz T, Sweeney A, Calzada G, Roberts DB, Levine NB, DeMonte F, Hanna EY, Kupferman ME.

Head Neck. 2014 Oct;36(10):1490-6. doi: 10.1002/hed.23485. Epub 2014 Jan 29.

PMID:
23996784
50.

Undertreatment of thick head and neck melanomas: an age-based analysis.

Monroe MM, Myers JN, Kupferman ME.

Ann Surg Oncol. 2013 Dec;20(13):4362-9. doi: 10.1245/s10434-013-3160-x. Epub 2013 Aug 23.

PMID:
23975303

Supplemental Content

Loading ...
Support Center